TFO
RGNX icon

Tarbox Family Office’s Regenxbio RGNX Stock Holding History

Tarbox Family Office’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,000
Closed -$39K – 1176
2021
Q2 		$39K Buy
1,000
+981
+5,163% +$35.1K 0.01% 280
2021
Q1 		$1K Hold
19
– – ﹤0.01% 1071
2020
Q4 		$1K Buy
+19
New +$664 ﹤0.01% 1042
2020
Q3 		– Sell
-29
Closed -$1K – 1194
2020
Q2 		$1K Buy
29
+18
+164% +$671 ﹤0.01% 1039
2020
Q1 		$0 Sell
11
-36
-77% -$1.5K ﹤0.01% 1274
2019
Q4 		$2K Buy
+47
New +$1.86K ﹤0.01% 839

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Tarbox Family Office's RGNX Position: Q3 2021 in Review

Tarbox Family Office sold out of Regenxbio (RGNX) in Q3 2021, closing a stake of 1,000 shares — an estimated $39K sold.

Tarbox Family Office first reported a position in RGNX in Q4 2019 and held it in 6 quarters. The position peaked at $39K in Q2 2021. 182 funds tracked by Wall St. Rank hold RGNX as of Q3 2021.

  • Tarbox Family Office reported no remaining Regenxbio position as of Q3 2021 after selling out during the quarter.
  • Tarbox Family Office sold 1,000 Regenxbio shares in Q3 2021, an estimated $39K.
  • Tarbox Family Office first reported a position in Regenxbio in Q4 2019 and held it in 6 quarters.
  • Tarbox Family Office's Regenxbio position peaked at $39K in Q2 2021.
  • 182 funds tracked by Wall St. Rank held Regenxbio as of Q3 2021.

Based on Tarbox Family Office's 13F filing for Q3 2021, filed 12 Oct 2021.